Viewing StudyNCT04001621



Ignite Creation Date: 2024-05-06 @ 1:23 PM
Last Modification Date: 2024-10-26 @ 1:13 PM
Study NCT ID: NCT04001621
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2022-12-08
First Post: 2019-06-27

Brief Title: Pyrotinib in Combination With Capecitabine in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer
Sponsor: Fudan University
Organization: Fudan University

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-06-26
Start Date Type: ACTUAL
Primary Completion Date: 2023-05-31
Primary Completion Date Type: ESTIMATED
Completion Date: 2023-12-31
Completion Date Type: ESTIMATED
First Submit Date: 2019-06-27
First Submit QC Date: June 27 2019
Study First Post Date: 2019-06-28
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-12-07
Last Update Post Date: 2022-12-08
Last Update Post Date Type: ACTUAL